Adjusting the role of hydroxychloroquine with or without azithromycin in patients with COVID-19
Taking recent publications into account, one should consider avoiding routine use of hydroxychloroquine, especially if combined with azithromycin, for COVID-19. Such treatment may be associated with the increased risk for hospital mortality and QT prolongation, while there is no documented effective...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Russo |
| Argitaratua: |
Izdatelstvo OKI
2020-10-01
|
| Saila: | Качественная клиническая практика |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.clinvest.ru/jour/article/view/527 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|